Tábi T - Search Results

1

Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice.

Szepesy J, Humli V, Farkas J, Miklya I, Tímár J, Tábi T, Gáborján A, Polony G, Szirmai Á, Tamás L, Köles L, Vizi ES, Zelles T. Szepesy J, et al. Among authors: tabi t. Int J Mol Sci. 2021 Mar 11;22(6):2853. doi: 10.3390/ijms22062853. Int J Mol Sci. 2021. PMID: 33799684 Free PMC article.

2

Inhibition of α2A-Adrenoceptors Ameliorates Dextran Sulfate Sodium-Induced Acute Intestinal Inflammation in Mice.

Zádori ZS, Tóth VE, Fehér Á, Al-Khrasani M, Puskár Z, Kozsurek M, Timár J, Tábi T, Helyes Z, Hein L, Holzer P, Gyires K. Zádori ZS, et al. Among authors: tabi t. J Pharmacol Exp Ther. 2016 Sep;358(3):483-91. doi: 10.1124/jpet.116.235101. Epub 2016 Jul 14. J Pharmacol Exp Ther. 2016. PMID: 27418171

3

Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model.

Mohammadzadeh A, Lakatos PP, Balogh M, Zádor F, Karádi DÁ, Zádori ZS, Király K, Galambos AR, Barsi S, Riba P, Benyhe S, Köles L, Tábi T, Szökő É, Harsing LG Jr, Al-Khrasani M. Mohammadzadeh A, et al. Among authors: tabi t. Int J Mol Sci. 2021 Mar 1;22(5):2479. doi: 10.3390/ijms22052479. Int J Mol Sci. 2021. PMID: 33804568 Free PMC article.

4

Differential Ganglioside and Cholesterol Depletion by Various Cyclodextrin Derivatives and Their Effect on Synaptosomal Glutamate Release.

Geda O, Tábi T, Lakatos PP, Szökő É. Geda O, et al. Among authors: tabi t. Int J Mol Sci. 2022 Aug 21;23(16):9460. doi: 10.3390/ijms23169460. Int J Mol Sci. 2022. PMID: 36012724 Free PMC article.

5

The Acute Antiallodynic Effect of Tolperisone in Rat Neuropathic Pain and Evaluation of Its Mechanism of Action.

Lakatos PP, Karádi DÁ, Galambos AR, Essmat N, Király K, Laufer R, Geda O, Zádori ZS, Tábi T, Al-Khrasani M, Szökő É. Lakatos PP, et al. Among authors: tabi t. Int J Mol Sci. 2022 Aug 24;23(17):9564. doi: 10.3390/ijms23179564. Int J Mol Sci. 2022. PMID: 36076962 Free PMC article.

6

Telmisartan Is a Promising Agent for Managing Neuropathic Pain and Delaying Opioid Analgesic Tolerance in Rats.

Karádi DÁ, Galambos AR, Lakatos PP, Apenberg J, Abbood SK, Balogh M, Király K, Riba P, Essmat N, Szűcs E, Benyhe S, Varga ZV, Szökő É, Tábi T, Al-Khrasani M. Karádi DÁ, et al. Among authors: tabi t. Int J Mol Sci. 2023 Apr 27;24(9):7970. doi: 10.3390/ijms24097970. Int J Mol Sci. 2023. PMID: 37175678 Free PMC article.

7

Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease.

Szökő É, Tábi T, Riederer P, Vécsei L, Magyar K. Szökő É, et al. Among authors: tabi t. J Neural Transm (Vienna). 2018 Nov;125(11):1735-1749. doi: 10.1007/s00702-018-1853-9. Epub 2018 Feb 7. J Neural Transm (Vienna). 2018. PMID: 29417334 Review.

8

Selegiline: a molecule with innovative potential.

Tábi T, Vécsei L, Youdim MB, Riederer P, Szökő É. Tábi T, et al. J Neural Transm (Vienna). 2020 May;127(5):831-842. doi: 10.1007/s00702-019-02082-0. Epub 2019 Sep 27. J Neural Transm (Vienna). 2020. PMID: 31562557 Free PMC article. Review.

9

Zachar G, Jakó T, Vincze I, Wagner Z, Tábi T, Bálint E, Mezey S, Szökő É, Csillag A. Zachar G, et al. Among authors: tabi t. Acta Biol Hung. 2018 Mar;69(1):1-15. doi: 10.1556/018.68.2018.1.1. Acta Biol Hung. 2018. PMID: 29575913 Free article.

10

The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease.

Tábi T, Szökő E, Vécsei L, Magyar K. Tábi T, et al. Expert Opin Drug Metab Toxicol. 2013 May;9(5):629-36. doi: 10.1517/17425255.2013.781152. Epub 2013 Mar 19. Expert Opin Drug Metab Toxicol. 2013. PMID: 23506388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page